MX2019009409A - Proteinas y composiciones de inmunizacion que contienen proteinas de pasteurella y metodos de uso. - Google Patents

Proteinas y composiciones de inmunizacion que contienen proteinas de pasteurella y metodos de uso.

Info

Publication number
MX2019009409A
MX2019009409A MX2019009409A MX2019009409A MX2019009409A MX 2019009409 A MX2019009409 A MX 2019009409A MX 2019009409 A MX2019009409 A MX 2019009409A MX 2019009409 A MX2019009409 A MX 2019009409A MX 2019009409 A MX2019009409 A MX 2019009409A
Authority
MX
Mexico
Prior art keywords
proteins
methods
compositions containing
immunizing compositions
pasteurella
Prior art date
Application number
MX2019009409A
Other languages
English (en)
Inventor
Emery Daryll
Nelson Carver Charles Iii
Original Assignee
Epitopix Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitopix Llc filed Critical Epitopix Llc
Publication of MX2019009409A publication Critical patent/MX2019009409A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)

Abstract

La presente invención proporciona proteínas aisladas que se pueden aislar de una pasteurella spp. Tal como P. multocida. La presente invención también proporciona composiciones que incluyen una o más de las proteínas, así como métodos para producirlas y métodos para usarlas.
MX2019009409A 2017-02-10 2018-02-09 Proteinas y composiciones de inmunizacion que contienen proteinas de pasteurella y metodos de uso. MX2019009409A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762457599P 2017-02-10 2017-02-10
PCT/US2018/017682 WO2018148586A1 (en) 2017-02-10 2018-02-09 Proteins and immunizing compositions containing pasteurella proteins and methods of use

Publications (1)

Publication Number Publication Date
MX2019009409A true MX2019009409A (es) 2019-09-27

Family

ID=61521820

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019009409A MX2019009409A (es) 2017-02-10 2018-02-09 Proteinas y composiciones de inmunizacion que contienen proteinas de pasteurella y metodos de uso.

Country Status (7)

Country Link
US (3) US10967056B2 (es)
EP (1) EP3579864B1 (es)
JP (2) JP7183168B2 (es)
BR (1) BR112019016564A2 (es)
ES (1) ES2945137T3 (es)
MX (1) MX2019009409A (es)
WO (1) WO2018148586A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117210593B (zh) * 2023-10-25 2024-06-14 四川省畜牧科学研究院 特异性检测多杀性巴氏杆菌和溶血性曼氏杆菌的引物组以及检测方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059503T5 (es) 1987-03-24 2000-01-16 Btg International Limited Comp Procedimiento para preparar una vacuna contra pasteurella.
EP0749321B1 (en) 1994-02-09 2007-01-24 Epitopix LLC Active immunization using a siderophore receptor protein
US5830479A (en) 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
WO1995025742A1 (en) 1994-03-22 1995-09-28 Pfizer Inc. Pasteurellaceae antigens and related vaccines
US5538733A (en) 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
NZ272660A (en) * 1994-07-29 1998-01-26 American Cyanamid Co Pasteurella multocida antigens, antibodies, their production and use
KR20060116041A (ko) * 1999-04-09 2006-11-13 파마시아 앤드 업존 캄파니 엘엘씨 항균성 백신 조성물
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
EP2431382A1 (en) 2005-01-21 2012-03-21 Epitopix, LLC Yersinia SPP, polypeptides and methods of use
WO2007006101A1 (en) 2005-07-13 2007-01-18 Monash University Surface proteins of pasteurella multocida
EP2256185B1 (en) * 2008-01-30 2014-09-10 Universitat Autònoma De Barcelona Heterologous protection against pasteurella multocida provided by p. multocida fur cells and the outer-membrane protein extracts thereof
EP2556085A2 (en) * 2010-04-05 2013-02-13 Bar-Ilan University Protease-activatable pore-forming polypeptides
US9308247B2 (en) 2011-03-25 2016-04-12 Kansas State University Research Foundation Compositions and methods for detecting, treating, and protecting against fusobacterium infection
WO2017011340A2 (en) 2015-07-10 2017-01-19 Epitopix, Llc. Proteins and immunizing compositions containing klebsiella proteins and methods of use

Also Published As

Publication number Publication date
BR112019016564A2 (pt) 2020-03-31
US11696945B2 (en) 2023-07-11
JP2022132447A (ja) 2022-09-08
US20200215177A1 (en) 2020-07-09
US20210205432A1 (en) 2021-07-08
WO2018148586A1 (en) 2018-08-16
WO2018148586A8 (en) 2018-10-11
JP2020511426A (ja) 2020-04-16
EP3579864B1 (en) 2023-04-12
ES2945137T3 (es) 2023-06-28
US10967056B2 (en) 2021-04-06
US20230414739A1 (en) 2023-12-28
EP3579864A1 (en) 2019-12-18
JP7183168B2 (ja) 2022-12-05

Similar Documents

Publication Publication Date Title
PH12021550337A1 (en) Anti-gdf15 antibodies, compositions and methods of use
PH12021500014A1 (en) Fused ring compounds
PH12018502225A1 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
MY194262A (en) Inhibitors of ret
MX2021014441A (es) Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos.
PH12019501973A1 (en) Anti-phf-tau antibodies and uses thereof
PH12018500457A1 (en) New phenoxymethyl derivatives
MX2019002946A (es) Anticuerpos anti-pd-1 y sus usos.
MX2020007799A (es) Inhibidores de cinasa no derrepresible de control de aminoacido general 2 (gcn2) y sus usos.
MX2018016038A (es) Compuestos y metodos para modular la funcion del acido ribonucleico (arn).
MX2017016169A (es) Anticuerpos anti-her2 y metodos de uso.
MX2018000395A (es) Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso.
MX2020013630A (es) Analogos de rapamicina y usos de los mismos.
PH12019501872A1 (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
MX2020001793A (es) Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos.
MX2022007841A (es) Degradadores del regulador dependiente de actina asociado a la matriz relacionado con el complejo switch/sacarosa no fermentable de la subfamilia a de la cromatina (smarca)y usos de los mismos.
MX2021006515A (es) Composiciones de methylobacterium para mejorar el rendimiento del maíz.
MX339461B (es) Polipeptidos y composiciones inmunizantes que contienen polipeptidos grampositivos y metodos de uso.
MX2020004093A (es) Puzolana de vidrio activada.
PH12017501601A1 (en) Use of isolated fractions of mastic gum for treating optic neuropathy
MX2021007141A (es) Sintesis de gamma-carbolinas fusionadas con heterociclo sustituido.
MX2019009409A (es) Proteinas y composiciones de inmunizacion que contienen proteinas de pasteurella y metodos de uso.
MX2021003888A (es) Nuevos compuestos utiles para el tratamiento de enfermedades cardiovasculares.
AU2019350356A8 (en) Arginase1 polypeptides
EP3737659A4 (en) COMPOSITIONS CONTAINING 2-CHLORO-1,1,1,2-TETRAFLUOROPROPANE (HCFC-244BB)